日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Alirocumab plus cemiplimab in advanced immuno-refractory metastatic non-small cell lung cancer: an ongoing multi-center phase II study

Alirocumab联合cemiplimab治疗晚期免疫难治性转移性非小细胞肺癌:一项正在进行的多中心II期研究

Oduah, Eziafa I; Zhang, Tian; Jung, Sin-Ho; Stinchcombe, Thomas E; Ready, Neal; Crawford, Jeffrey; Clarke, Jeffrey M; Gray, Jhanelle E; Antonia, Scott J

Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): conventional and distribution-based immune profiling of the tumor microenvironment and peripheral circulation

早期非小细胞肺癌(NSCLC)围手术期帕博利珠单抗治疗:肿瘤微环境和外周循环的常规及基于分布的免疫分析

Zhang, Jingxuan; Lin, Lin; Enzor, Jennifer H; Patel, Prekshaben H; Steadman, Katelyn N; Little, Victoria E; Gu, Lin; Oduah, Eziafa I; Tong, Betty C; Antonia, Scott J; Ready, Neal E; Weinhold, Kent J

Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis

早期非小细胞肺癌(NSCLC)围手术期帕博利珠单抗治疗:安全性、有效性和探索性生物标志物分析

Wood, Cameron; Lyniv, Liliana; Isaacs, James M; Kaufman, Jacob M; Oduah, Eziafa I; Clarke, Jeff; Crawford, Jeffrey; Stinchcombe, Thomas; Tong, Betty C; Wang, Xiaofei; Gu, Lin; Wigle, Dennis; Dragnev, Konstantin H; Antonia, Scott J; Weinhold, Kent; Ready, Neal

Neoadjuvant, Perioperative, and Adjuvant Immunotherapy in Early-Stage Surgically Resectable Non-Small Cell Lung Cancer: Updates and Future Perspectives

早期可手术切除的非小细胞肺癌的新辅助、围手术期和辅助免疫治疗:最新进展和未来展望

Gathers, Diamone; Oswalt, Cameron; Alder, Laura; Chen, Kevin; Higgins, Jordyn P; Clarke, Jeffrey M; Oduah, Eziafa I

Towards preventing the false alarms in indoor physical intrusion detector system and the incorporation of intruder immobilizer system

为了防止室内物理入侵探测系统出现误报,并整合入侵者防盗系统。

Oduah, Uzoma Ifeanyi; Oluwole, Daniel; Johnson, Samuel Olamilekan

ICTIS: A Novel Scoring System to Assess the Inclusivity of Advanced NSCLC Immunotherapy Trials

ICTIS:一种评估晚期非小细胞肺癌免疫疗法试验包容性的新型评分系统

Nguyen, Kira; Wei, Ashley; Govindan, Srinivas; Oduah, Eziafa; Seetharamu, Nagashree; Aung, Wint Yan

Sotorasib for the treatment of locally advanced/metastatic non-small cell lung cancer

索托拉西布用于治疗局部晚期/转移性非小细胞肺癌

Higgins, Jordyn P; Carlisle, Jennifer W; Moniri, Nader H; Gupta, Shruti; Oduah, Eziafa I; Leal, Ticiana

In-Hospital Mortality Risk Among Transfers to Cardiac Intensive Care Units

转入心脏重症监护病房患者的院内死亡风险

Phreaner, Nicholas; Villela, Miguel Alvarez; Bennett, Courtney E; Kenigsberg, Benjamin B; Ding, Xuan; Durowoju, Rasheed O; Fenerty, Anna; Li, Boyangzi; Martillo Correa, Miguel A; Menon, Venu; Nair, Raunak M; Newby, L Kristin; Oduah, Mary-Tiffany; Papolos, Alexander I; Morrow, David A; Daniels, Lori B

Proteasome inhibition paradoxically degrades gain-of-function mutant p53 R273H in NSCLC and could have therapeutic implications

蛋白酶体抑制反而会降低 NSCLC 中的获得功能突变 p53 R273H,并可能具有治疗意义

Eziafa I Oduah, Susan T Sharfstein, Nagashree Seetharamu, Steven R Grossman, Larisa Litovchick

Oncogenic Mutant p53 Sensitizes Non-Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress-Dependent Induction of Mitochondrial Apoptosis

致癌突变 p53 通过氧化应激依赖性诱导线粒体凋亡使非小细胞肺癌细胞对蛋白酶体抑制敏感

Kranthi Kumar Chougoni #, Victoria Neely #, Boxiao Ding, Eziafa Oduah, Vianna T Lam, Bin Hu, Jennifer E Koblinski, Bradford E Windle, Swati Palit Deb, Sumitra Deb, Jorge J Nieva, Senthil K Radhakrishnan, Hisashi Harada, Steven R Grossman